Source:http://linkedlifedata.com/resource/pubmed/id/20633797
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-7-16
|
pubmed:abstractText |
Photodynamic therapy requires a photosensitizer, oxygen, and activating light. For acne, pilosebaceous units are "target" structures. Porphyrins are synthesized in vivo from 5-aminolevulinic acid (ALA), particularly in pilosebaceous units. Different photosensitizers and drug delivery methods have been reported for acne treatment. There are a variety of porphyrin precursors with different pharmacokinetic properties. Among them, ALA and methyl-ester of ALA (MAL) are available for possible off-label treatment of acne vulgaris. In addition, various light sources, light dosimetry, drug incubation time, and pre- and posttreatment care also change efficacy and side effects. None of these variables has been optimized for acne treatment, but a number of clinical trials provide helpful guidance. In this paper, we critically analyze clinical trials, case reports, and series of cases published through 2009. LEARNING OBJECTIVES: After completing this learning activity, participants should be able to analyze photodynamic therapy using 5-aminolevulinic acid and its derivates for acne treatment, predict the effectiveness and outcomes of photodynamic therapy using different parameters and/or different porphyrin-related photosensitizers, and assess and manage the side effects of porphyrin-based photodynamic therapy for acne.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1097-6787
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
195-211; quiz 211-2
|
pubmed:meshHeading |
pubmed-meshheading:20633797-Acne Vulgaris,
pubmed-meshheading:20633797-Aminolevulinic Acid,
pubmed-meshheading:20633797-Dermatology,
pubmed-meshheading:20633797-Education, Medical, Continuing,
pubmed-meshheading:20633797-Humans,
pubmed-meshheading:20633797-Laser Therapy,
pubmed-meshheading:20633797-Photochemotherapy
|
pubmed:year |
2010
|
pubmed:articleTitle |
Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part II. Understanding parameters for acne treatment with photodynamic therapy.
|
pubmed:affiliation |
Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
|
pubmed:publicationType |
Journal Article,
Review
|